Lusopress

Medicinal product

(Invented) name

Lusopress

Active substance (s)

Nitrendipinas

Strength

20 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C08CA08, Nitrendipine

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-06-26

Date of renewal

Documents

2662_Lusopress 20 mg tabletės_PZ_2025-06-26.docx

2662_Lusopress 20 mg tabletės_PL_2025-06-26.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Nitrendipinas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
117877	103982	1103982	lizdinė plokštelė	N28		Receptinis	LT/L/25/2662/001	Netiekiama	-	-	No	-	-	Download
117878	103983	1103983	lizdinė plokštelė	N98		Receptinis	LT/L/25/2662/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-06-26	Registruotas